Patents by Inventor Garry Thomas Gwozdz

Garry Thomas Gwozdz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of benzodiazepine compositions
    Patent number: 11793786
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: October 24, 2023
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20230104144
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 6, 2023
    Applicant: Neurelis, Inc.
    Inventors: Steve CARTT, David MEDEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David F. HALE, Edward T. MAGGIO
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220241187
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 15, 2022
    Publication date: August 4, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220117887
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: June 2, 2021
    Publication date: April 21, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220062227
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 12, 2021
    Publication date: March 3, 2022
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Administration of benzodiazepine compositions
    Patent number: 11241414
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: February 8, 2022
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20210299089
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 30, 2021
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Pharmaceutical compositions
    Patent number: 10478409
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula I wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: November 19, 2019
    Assignee: Kalvista Pharmaceuticals Limited
    Inventors: Gary Paul Cook, Garry Thomas Gwozdz, Theodore Patrick Laslo
  • DELIVERY DEVICES CONTAINING ENCAPSULATED AND/OR PARTICLE-BOUND ACTIVE PHARMACEUTICAL INGREDIENTS
    Publication number: 20190254974
    Abstract: Delivery devices of a degradable or nondegradable biocompatible matrix with one or more encapsulated active pharmaceutical ingredients or one or more particle-bound active pharmaceutical ingredients dispersed in the matrix are provided. Also provided are methods for delivering an active pharmaceutical ingredient to a subject with these delivery devices. Modified vaginal rings are also provided as well as surface coatings for delivery devices which minimize bio-interaction of the coated delivery devices.
    Type: Application
    Filed: March 4, 2019
    Publication date: August 22, 2019
    Applicant: PARTICLE SCIENCES, INC.
    Inventors: David FAIRHURST, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, Abhijit GOKHALE
  • Delivery devices containing encapsulated and/or practice-bound active pharmaceutical ingredients
    Patent number: 10258571
    Abstract: Delivery devices of a degradable or nondegradable biocompatible matrix with one or more encapsulated active pharmaceutical ingredients or one or more particle-bound active pharmaceutical ingredients dispersed in the matrix are provided. Also provided are methods for delivering an active pharmaceutical ingredient to a subject with these delivery devices. Modified vaginal rings are also provided as well as surface coatings for delivery devices which minimize bio-interaction of the coated delivery devices.
    Type: Grant
    Filed: February 12, 2008
    Date of Patent: April 16, 2019
    Assignee: PARTICLE SCIENCES, INC.
    Inventors: David Fairhurst, Garry Thomas Gwozdz, Mark Mitchnick, Abhijit Gokhale, Andrew Loxley
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20180235929
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 17, 2018
    Publication date: August 23, 2018
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Pharmaceutical Compositions
    Publication number: 20180021271
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula I wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Application
    Filed: September 26, 2017
    Publication date: January 25, 2018
    Inventors: Gary Paul COOK, Garry Thomas GWOZDZ, Theodore Patrick LASLO
  • Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities
    Patent number: 9849100
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula (I) (Formula (I)), wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: December 26, 2017
    Assignee: Kalvista Pharmaceuticals Limited
    Inventors: Gary Paul Cook, Garry Thomas Gwozdz, Theodore Patrick Laslo
  • Administration of benzodiazepine compositions
    Patent number: 9763876
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: September 19, 2017
    Assignee: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20170196884
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: March 27, 2017
    Publication date: July 13, 2017
    Inventors: Steve CARTT, David MADEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David HALE, Edward T. MAGGIO
  • Nanoparticle Delivery of TLR Agonists and Antigens
    Publication number: 20160000905
    Abstract: Compositions of one or more TLR agonists and one or more antigens adsorbed or attached to the same particles or to different particles are provided. Also provided are methods for producing and using these compositions.
    Type: Application
    Filed: February 24, 2014
    Publication date: January 7, 2016
    Inventors: Mark Mitchnick, Andrew Loxley, Garry Thomas Gwozdz
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20150342910
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula (I) (Formula (I)), wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Application
    Filed: January 9, 2014
    Publication date: December 3, 2015
    Applicant: KalVista Pharmaceuticals Limited
    Inventors: Gary Paul COOK, Garry Thomas GWOZDZ, Theodore Patrick LASLO
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20150065491
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: October 29, 2014
    Publication date: March 5, 2015
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Administration of benzodiazepine compositions
    Patent number: 8895546
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: November 25, 2014
    Assignee: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20130065886
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: June 13, 2012
    Publication date: March 14, 2013
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio